
View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1. Constructs and western blot of INF2. (A) Constructs used in this study: INF2 (full-length protein, 1273 amino acids), INF2-W (full-length protein, triple L A mutation in DAD/WH2 domain, red star), INF2-C1270S (full-length protein, C1270S mutation, position indicated by blue star), INF2-(FH1-FH2-C) (residues 536-1273), INF2-(DID) (residues 1-424), INF2-(C) (residues 993-1273) and INF2-(C)-W (amino acids 993-1273 with triple L A mutation in DAD/WH2 domain, red star). (B) Western blot of Swiss 3T3 extract was performed using affinity-purified INF2 antibody [raised against INF2-(C) construct]. (C) INF2 western blots on 10 µg of extract. From left to right: brain (B), heart (H), 3T3 cells (3T3), liver (L) and spleen (S). Upper image shows processing such that none of the INF2 bands are saturated. Lower image shows processing such that brain and 3T3 samples are strongly overprocessed, which reveals lighter bands in heart, liver, and spleen. (D) Cellular fractionation of endogenous INF2. The homogenate (H) was centrifuged at 2000 x g for 10 minutes to create the low-speed pellet (LSP). The supernatant from this centrifugation was centrifuged at 436,000 x g for 20 minutes to create the high-speed pellet (HSP) and high-speed supernatant (HSS). Fractions were separated by SDS-PAGE then probed for INF2 in western blots. (E) Extraction of INF2. The LSS fraction from 3T3 extract was treated with high ionic strength (1 M NaCl), high pH (100 mM CAPS pH 11), or non-ionic detergent (2% thesit), then centrifuged at 436,000 x g for 20 minutes to create a pellet (P) and a supernatant (S) fraction. Fractions were separated by SDS-PAGE then probed for INF2, tubulin, and syntaxin 6 by western blot.
|